NCT04812327

Capturing Infectious COVID-19 Asymptomatic Cases in Singapore

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Becton, Dickinson and Company · Industry
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

This study is being conducted to assess the performance of the BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2, used in serial testing, in identification of infectious, asymptomatic individuals. This information may be used to inform development of an effective testing strategy by policy makers.

Detailed description

This multi-center, prospective, observational, diagnostic evaluation study is designed to assess the performance of the BD Veritor System in the detection of SARS-CoV-2 in asymptomatic individuals compared to viral culture and a commercially available RT-PCR assay over multiple testing time points. The study will enroll a minimum of 150 asymptomatic, adult participants who test positive for SARS-CoV-2 during community/traveler screening procedures.

Conditions

• Covid19
• SARS CoV-2

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	BD Veritor Plus System for Rapid Detection of SARS CoV-2	Nasal Sawb for the conduct of the Veritor Antigen Test
DIAGNOSTIC_TEST	rt-PCR	Nasopharyngeal Swab for the conduct of a rt-PCR
DIAGNOSTIC_TEST	viral culture	Nasopharyngeal Swab for the conduct of viral culture

Timeline

• Start date: 2021-06-01
• Primary completion: 2021-09-01
• Completion: 2021-11-01
• First posted: 2021-03-23
• Last updated: 2021-08-11

Locations

1 site across 1 country: Singapore